A case report of constrictive pericarditis following COVID-19 vaccination.
Eric BainMaya E GuglinPublished in: European heart journal. Case reports (2023)
The patient developed progressive symptoms within 2 weeks of his second Pfizer vaccine. Echocardiogram and CMR had classic signs of CP, and pericardial pathology confirmed fibrotic pericardium. The patient had no prior surgery, thoracic radiation, or bacterial infection. Epstein-Barr Virus viraemia was thought to be reactionary, and histoplasmosis complement likely represented chronic exposure. The timing of symptoms and negative multidisciplinary workup raises the suspicion for COVID vaccine-induced CP. The COVID vaccines benefits far exceed the risks, but complications still can occur. Practitioners should have a high index of suspicion to allow prompt diagnosis of CP.
Keyphrases
- coronavirus disease
- epstein barr virus
- sars cov
- case report
- diffuse large b cell lymphoma
- minimally invasive
- primary care
- multiple sclerosis
- coronary artery bypass
- risk factors
- high glucose
- radiation therapy
- acute coronary syndrome
- percutaneous coronary intervention
- coronary artery disease
- general practice
- climate change
- preterm birth